Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population

Pharmacogenetic landscape of clopidogrel in north Indians suggest distinct interpopulation differences in allele frequencies

(2014) Anil K Giri et al.   PHARMACOGENOMICS

Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21

(2012) R. Tabassum et al.   DIABETES

A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms

(2012) Michela Cini et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Prediction of warfarin dose: why, when and how?

(2012) Niclas Eriksson et al.   PHARMACOGENOMICS

Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations

(2010) Gin Gin Gan et al.   ANNALS OF HEMATOLOGY

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

(2010) N. A. Limdi et al.   BLOOD

CombinedCYP2C9,VKORC1andCYP4F2frequencies among racial and ethnic groups

(2010) Stuart A Scott et al.   PHARMACOGENOMICS

Reconstructing Indian population history

(2009) David Reich et al.   NATURE

VKORC1haplotypes in five East-Asian populations and Indians

(2009) Ming Ta Michael Lee et al.   PHARMACOGENOMICS

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

(2009) Fumihiko Takeuchi et al.   PLoS Genetics

Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement

(2008) D. Wang et al.   BLOOD

Genetic landscape of the people of India: a canvas for disease gene exploration

(2008)   JOURNAL OF GENETICS

Pharmacogenomics and treatment for dementia induced by Alzheimer’s disease

(2008) Meenal Gupta et al.   PHARMACOGENOMICS

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

(2003) Young-Ran Yoon et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY